Loading...
•
Aug 31, 2025
Neogen Q1 2026 Earnings Report
Neogen reported Q1 2026 earnings with a GAAP profit driven by a one-time gain, though adjusted earnings declined due to operating challenges.
Key Takeaways
Neogen posted a net income of $36.3 million for Q1 2026, primarily due to a non-cash gain from the divestiture of its Cleaners & Disinfectants business. However, core operations showed weakness, with a drop in both adjusted EPS and revenue.
Reported GAAP net income of $36.3M, supported by a $76.4M gain from divestiture
Adjusted net income declined to $9.4M due to lower operating income
Revenue fell to $209.2M, with headwinds from divestitures and product discontinuations
Reaffirmed full-year guidance and implemented restructuring actions to reduce costs
Revenue by Segment
Forward Guidance
Neogen reaffirmed its FY26 outlook, expecting revenues between $820M and $840M and Adjusted EBITDA between $165M and $175M.
Positive Outlook
- Full-year revenue guidance reaffirmed
- Adjusted EBITDA guidance maintained
- Debt reduced by $100M from divestiture proceeds
- Strong growth in Bacterial & Sanitation and Genomics product lines
- Operational changes expected to drive long-term margin expansion
Challenges Ahead
- Adjusted EPS declined from prior year
- Gross margin fell due to integration costs and tariffs
- Revenue decline driven by divestitures and product line discontinuations
- Higher operating expenses reduced profitability
- Restructuring involved headcount reductions
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...